Stemcells (NASDAQ: STEM) reported Q1 EPS of ($0.14), $0.02 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $339 thousand versus the consensus estimate of $240 thousand.

For earnings history and earnings-related data on Stemcells (STEM) click here.